Serine protease inhibitors restrict host susceptibility to SARS-CoV-2 infections

E Rosendal, IS Mihai, M Becker, D Das, L Frängsmyr… - MBio, 2022 - Am Soc Microbiol
ABSTRACT The coronavirus disease 2019, COVID-19, is a complex disease with a wide
range of symptoms from asymptomatic infections to severe acute respiratory syndrome with …

Structure, activity and inhibition of human TMPRSS2, a protease implicated in SARS-CoV-2 activation

BJ Fraser, S Beldar, A Seitova, A Hutchinson… - BioRxiv, 2021 - biorxiv.org
ABSTRACT Transmembrane protease, serine 2 (TMPRSS2) has been identified as key host
cell factor for viral entry and pathogenesis of SARS-coronavirus-2 (SARS-CoV-2) …

Structure-based phylogeny identifies avoralstat as a TMPRSS2 inhibitor that prevents SARS-CoV-2 infection in mice

YJ Sun, G Velez, DE Parsons, K Li… - The Journal of …, 2021 - Am Soc Clin Investig
Drugs targeting host proteins can act prophylactically to reduce viral burden early in disease
and limit morbidity, even with antivirals and vaccination. Transmembrane serine protease 2 …

Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2

AZ Abbasi, DA Kiyani, SM Hamid… - Journal of Medical …, 2021 - Wiley Online Library
Epidemiological data shows a discrepancy in COVID‐19 susceptibility and outcomes with
some regions being more heavily affected than others. However, the factors that determine …

The Transmembrane protease serine 2 (TMPRSS2) non-protease domains regulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike …

R Strobelt, J Adler, Y Shaul - Viruses, 2023 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters cells by binding
to the angiotensin-converting enzyme 2 (hACE2) receptor. This process is aided by the …

A Review on Expression, Pathological Roles, and Inhibition of TMPRSS2, the Serine Protease Responsible for SARS‐CoV‐2 Spike Protein Activation

J Sarker, P Das, S Sarker, AK Roy, AZMR Momen - Scientifica, 2021 - Wiley Online Library
SARS‐CoV‐2, the coronavirus responsible for the COVID‐19 pandemic, uses the host cell
membrane receptor angiotensin‐converting enzyme 2 (ACE2) for anchoring its spike …

A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in mice

T Shapira, IA Monreal, SP Dion, M Jager, A Désilets… - bioRxiv, 2021 - biorxiv.org
The COVID-19 pandemic caused by the SARS-CoV-2 virus remains a global public health
crisis. Although widespread vaccination campaigns are underway, their efficacy is reduced …

[HTML][HTML] Alpha 1 antitrypsin is an inhibitor of the SARS-CoV-2–priming protease TMPRSS2

NP Azouz, AM Klingler, V Callahan… - Pathogens And …, 2021 - ncbi.nlm.nih.gov
Background: Host proteases have been suggested to be crucial for dissemination of MERS,
SARS-CoV, and SARS-CoV-2 coronaviruses, but the relative contribution of membrane …

Discovery of TMPRSS2 inhibitors from virtual screening as a potential treatment of COVID-19

X Hu, JH Shrimp, H Guo, M Xu, CZ Chen… - ACS pharmacology & …, 2021 - ACS Publications
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has
prompted researchers to pivot their efforts to finding antiviral compounds and vaccines. In …

TMPRSS11D and TMPRSS13 activate the SARS-CoV-2 spike protein

M Kishimoto, K Uemura, T Sanaki, A Sato, WW Hall… - Viruses, 2021 - mdpi.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) utilizes host proteases,
including a plasma membrane-associated transmembrane protease, serine 2 (TMPRSS2) to …